PARABOLIC Return On Asset

<div class='circular--portrait' style='background:#FF01C9;color: #FFF8DC;font-size:4em;padding-top: 25px;;'>PD</div>
PARABOLIC DRUGS return on asset fundamental analysis lookup allows you to check this and other indicators for PARABOLIC DRUGS or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please continue to Equity Screeners to view more equity screening tools

Search Return On Asset

 
Refresh

PARABOLIC Return On Asset Analysis

Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Return on Asset 
 = 
Net Income 
Total Assets 
X
100 
More About Return On Asset | All Equity Analysis

Current PARABOLIC DRUGS Return On Asset

(11.19) 

About Return On Asset

Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.Compare to competition
Based on latest financial disclosure PARABOLIC DRUGS has Return On Asset of -11.19%. This is 27.89% higher than that of the Healthcare sector, and 71.33% lower than that of Drugs - Generic industry, The Return On Asset for all stocks is 7892.86% higher than the company.

Did you try this?

Run Money Managers Now

   

Money Managers

Screen money managers from public funds and ETFs managed around the world
All  Next Launch Module

PARABOLIC Fundamentals



Current Sentiment - PARABDRUGS-EQ

PARABOLIC DRUGS Investor Sentiment

Macroaxis portfolio users are evenly split in their perspective on investing in PARABOLIC DRUGS. What is your perspective on investing in PARABOLIC DRUGS? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Currently Active Assets on Macroaxis

C   
Purchased over 60 shares of
few hours ago
Traded for 44.1
VMW   
Purchased over 20 shares of
few hours ago
Traded for 134.6
CRM   
Purchased few shares of
few hours ago
Traded for 177.85
S   
Purchased over 300 shares of
few hours ago
Traded for 8.62
GOOG   
Purchased few shares of
few hours ago
Traded for 1410.42
Check out Your Equity Center. Please also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.


 
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page